Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Impel Pharmaceuticals (IMPL)

Impel Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMPL
DateTimeSourceHeadlineSymbolCompany
09/04/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMPLImpel Pharmaceuticals Inc
16/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202422:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202422:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202422:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202422:16Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
02/01/202421:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
26/12/202321:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMPLImpel Pharmaceuticals Inc
18/12/202313:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
04/12/202311:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
14/11/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
02/11/202321:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
16/10/202321:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
05/10/202322:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMPLImpel Pharmaceuticals Inc
05/10/202313:00GlobeNewswire Inc.Impel Pharmaceuticals Announces Exploration of Strategic AlternativesNASDAQ:IMPLImpel Pharmaceuticals Inc
04/10/202322:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
19/09/202302:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
07/09/202321:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
21/08/202313:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
18/08/202314:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMPLImpel Pharmaceuticals Inc
15/08/202321:29Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:IMPLImpel Pharmaceuticals Inc
05/07/202315:05AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202311:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202311:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202311:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202311:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202311:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
15/06/202313:00GlobeNewswire Inc.Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache SocietyNASDAQ:IMPLImpel Pharmaceuticals Inc
12/05/202321:23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMPLImpel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IMPL